Canaccord Genuity
Canaccord Genuity is the global capital markets division of Canaccord Financial Inc. (CF : TSX | CF. : AIM), offering institutional and corporate clients idea-driven investment banking, research, sales and trading services.
The companies has operations in 24 cities worldwide and the ability to list companies on 10 stock exchanges.
View Older Stories View More Recent Stories
-
Canaccord Genuity Reiterates Buy Rating on Coty (COTY), 'see any pullback as a buying opportunity'
-
Canaccord Genuity Starts MCAN Mortgage Corp (MKP:CN) at Buy
-
Canaccord Genuity Reiterates Buy Rating on Solo Brands (DTC)
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 11 10 2024] - (CGWL)
-
Form 8.3 - [ECKOH PLC - 11 10 2024] - (CGWL)
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 11 10 2024] - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Tesla (TSLA)
-
Canaccord Genuity Starts Tyro Payments Limited (TYR:AU) (TYPMF) at Buy
-
Givex Mails Management Information Circular for Special Meeting of Shareholders
-
Pluribus Technologies Corp. Announces Sale of POWR Inc., Assured Software Ltd., Rowanwood Professional Services Limited and Cranham Haig Limited
-
Form 8.3 - [KEYWORDS STUDIOS PLC - 10 10 2024] - (CGWL)
-
Form 8.3 - [ECKOH PLC - 10 10 2024] - (CGWL)
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 10 10 2024] - (CGWL)
-
Cardiol Therapeutics Announces Exercise and Closing of Over-Allotment Option
-
Canaccord Genuity Reiterates Buy Rating on Alnylam Pharmaceuticals (ALNY)
-
Canaccord Genuity Reiterates Buy Rating on Holley (HLLY)
-
Canaccord Genuity Reiterates Buy Rating on Hims and Hers (HIMS)
-
CeriBell (CBLL) Prices Upsized 10.61M Share IPO at $17/sh
-
CeriBell, Inc. Announces Pricing of Upsized Initial Public Offering
-
Canaccord Genuity Reiterates Buy Rating on Itron (ITRI)
-
Canaccord Genuity Reiterates Hold Rating on InMode Ltd. (INMD)
-
Publication of a Circular - Notice of General Meeting
-
Form 8.3 - [LEARNING TECHNOLOGIES GROUP PLC - 09 10 2024] - (CGWL)
-
Form 8.3 - [KEYWORDS STUDIOS PLC] - 09 10 2024 - (CGWL)
-
Form 8.3 - [ECKOH PLC - 09 10 2024] - (CGWL)
-
Cardiol Therapeutics Announces Closing of US$13.5 Million Public Offering of Common Shares
-
Canaccord Genuity Reiterates Hold Rating on Illumina (ILMN)
-
Canaccord Genuity Reiterates Buy Rating on Clene, Inc. (CLNN)
-
10X Genomics (TXG) PT Lowered to $20 at Canaccord Genuity
-
Atlassian Corporation (TEAM) PT Raised to $225 at Canaccord Genuity
-
Helen of Troy (HELE) PT Raised to $92 at Canaccord Genuity
-
Publication of a Prospectus and Relevant Related Party Transaction
-
Beringer Capital Portfolio Company, Dig Insights, Expands Innovation Capabilities with the Acquisitions of Ebco Trends and Ignite 360
-
Form 8.3 - [ECKOH PLC - 08 10 2024] - (CGWL)
-
Arizona Sonoran Announces Closing of C$34.5 Million Upsized Bought Deal Offering
-
Form 8.3 - [KEYWORDS STUDIOS PLC] - 08 10 2024 - (CGWL)
-
Cardiol Therapeutics (CRDL) Announces Pricing of Public Offering of Common Shares
-
Cardiol Therapeutics Announces Pricing of Public Offering of Common Shares
-
Canaccord Genuity Reiterates Buy Rating on Regulus Therapeutics (RGLS)
-
Canaccord Genuity Reiterates Hold Rating on Worthington Industries (WOR)
-
Zeta Global Holdings Corp (ZETA) PT Raised to $35 at Canaccord Genuity
-
Accolade Inc. (ACCD) PT Lowered to $7 at Canaccord Genuity
-
Golden Spike Announces Closing of Private Placement Offerings Raising $2.39 Million, with Participation by Mr. Eric Sprott
-
Cardiol Therapeutics (CRDL) Files Preliminary Prospectus Supplement for Proposed Share Offering
-
Cardiol Therapeutics Files Preliminary Prospectus Supplement for Proposed Public Offering of Common Shares
-
$28,269,550 Raised on Initial Closing. Books now re-open for a final closing on October 30, 2024
-
Canaccord Genuity Reiterates Hold Rating on Surf Air Mobility (SRFM) on Palantir Technologies stake expansion
-
Form 8.3 - [KEYWORDS STUDIOS PLC] - 07 10 2024 - (CGWL)
-
Canaccord Genuity Reiterates Buy Rating on Generac Holdings (GNRC)
-
Arizona Sonoran Announces Filing of Final Short Form Prospectus in connection with C$30,000,000 Bought Deal Financing

